SOMX, buy out news 12-11. If you were in, congrats!!
12-11 9:10 AM Somaxon Pharmaceuticals (SOMX) +103.4% premarket after agreeing to be acquired by Pernix Therapeutics (PTX) in a stock-for-stock transaction valued at $25M. (Read the comments on this)
See more Market Currents on Healthcare, M&A, On the Move
Recent articles on SOMX:
Why Somaxon Pharmaceuticals Should Be A Double From Here by
BuySellShort
Somaxon Pharmaceuticals, Inc.'s CEO Discusses Q3 2012 Results -
Earnings Call Transcript
Somaxon Pharmaceuticals' CEO Discusses Q2 2012 Results - Earnings Call Transcript